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spa type t030, t037 and t067. All MRSA isolates were divided to
11 types and about 20 subtypes with coa typing method here.
The discriminate power of this coa typing method was better
than MLST or spa method.
Conclusion: It demonstrated that this sequence-based coa typing
method was a simple, rapid and effective technique applica-
ble for outbreak or local nosocomial MRSA investigations in the
future.
OL-036 Detection Streptococcus pneumoniae and
identiﬁcation of serotype in cerebral spinal ﬂuid
of childhood bacterial meningitis in China
Gang Liu*,1, Erqing Zhang1, Fanrong Kong2, Heying Chen1,
Gilbert Lyn2, Shaoying Li 1. 1Beijing Children’s Hospital Capital
Univeristy of Medical Sciences, Beijing, China; 2CIDM, ICPMR,
Westmead Hospital Sydney, Australia
Objective: We aimed to a) apply PCR for identiﬁcation of S.
Pneumoniae pneumolysin from cerebral spinal ﬂuid samples of
patients with bacterial meningitis; b) apply nested PCR for
detection of serotype (serogroups) of S pneumonia cpsA-cpsB
combined with sequencing and serotype (group) speciﬁc PCR.
Methods: From January 2006 to December 2008, a total number
of 111 CSF samples of cases strictly met bacterial meningitis
diagnosis criteria were investigated.
Results: Combining positive ﬁnding by all PCRs and culture, the
positive ratio of S. pneumoniaemeningitis was 14.4% in this study.
The serotype was identiﬁed in 9 cases. The distribution was two
serotype 14, two serotype 10A, and one for each serotype 2, 5,
19F, 9N and 23 F separately. It was different with the carriage
studies in China and others with respiratory infection studies.
Conclusions: Serotype study including more bacterial meningitis
cases should be included to obtain a more complete description
of invasive S. pneumonia serotype distribution.
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OL-037 Cross-drug resistance of harboring drug resistant
HIV-1 subtypes B’ strains isolated from Chinese
Center Regional former donor blood patients
experienced HAART treatment
Liying Ma*, Jianghong Huang, Hui Xing, Yiming Shao. Chinese
Center for Disease Control and Prevention
This study analysed the genetic and phenotypic cross drug re-
sistance of harboring resistant viruses from therapy failure AIDS
patients in order to better design anti-HIV-1 regimens for future
treatment of HIV/AIDS patients in China.
65 AIDS patients (49 for D4T/DDI/NVP treatment; 16 for AZT/
DDI/NVP treatment) were recruited and the drug resistance was
analysed using plasma RNA extract,RT-PCR and sequence. HIV
viruses were further isolated from the patients’ PBMC and used
for phenotypic drug resistance by an in vitro susceptibility drug
test.
All the patients were infected by HIV-1B’ subtype and harbored
drug resistance to HIV-1 nucleoside reverse transcriptase (RT)
inhibitors, in which 98% is NVP, 51% is AZT, 60% is D4T, 57% is DDI.
In these HIV-1 viruses harboring resistant strains, there are 100%
cross drug resistance to EFV, 92% to DLV, 77% to TDF, 42% to 3TC,
42% to FTC, and 84% to ABC in these therapy regimen without
ABC, 3TC, FTC, TDF, EFV and DLV. Phenotypic drug resistance
showed that the accordance rate between genotypic drug resis-
tance and phenotypic drug resistance in high and intermediate
drug resistance of 3TC, FTC, EFV and ABC is 72%, 78%, 94% and
89% respectively.
There is cross-drug resistance to HIV-1 nucleoside reverse
transcriptase (RT) inhibitors of Chinese AIDS Patients harboring
resistant strains especially EFV and then ABC, FTC and 3TC. This
information will help to rationally design more efﬁcient anti-HIV-
1 regimens for future treatment of HIV/AIDS patients in China.
OL-038 NRTIs’ effects on the quantity of mitochondrial
DNA and HR II in HIV/AIDS patients
Yasong Wu*, Xinyue Chen, Ying Shi, Hao Wu, Dexi Chen, Yu Sun.
STD/AIDS Research Center, Beijing Youan Hospital, Capital
Medical University
Aim: To know NRTIs’ effects on the sequences of hyper variable
region (HR) of mitochondria and the quantity of mitochondrial
DNA (mtDNA).
Methods: 32 HIV/AIDS patients who were receiving ART for more
than 3 years in which 17 had lipodystrophy had been studied.
PBMC were collected at baseline, 6-month, and 2-year after ART.
Total DNA was extracted from PBMCs. MtDNA were examined us-
ing real time PCR. About 700bp fragment which contains HR II of
these individuals PBMCs were ampliﬁed by standard PCR. Alter-
ations were determined by DNA sequencing assay and comparing
with the revised Cambridge Reference Sequence.
Results: mtDNA’s quantity decreased at 6-mouth and 2-year of
ART compare with that of basement. 6 new mutations appeared
in 5 individuals with lipodystrophy at 2-year of ART compared
with basement.
Conclusions: NRTIs could reduce mtDNA’s quantity of PBMC and
might induce mutation. More comprehensive study should be
developed.
OL-039 Initial viral loads and CD4 counts in a cohort of
adolescents presenting with HIV infection
Alicia K. Rapson1, Daniel H. Conway1,2, Roberta Laguerre1,2,
Janet Chen1,2, Jill A. Foster*,1,2. 1St. Christopher’s Hospital for
Children; 2Drexel University College of Medicine
Background: Little data exists about adolescents who acquire
HIV behaviorally and present with CD4 counts meeting US guide-
lines for HAART initiation.
Methods: Retrospective record review was performed record-
ing initial CD4 counts, viral loads for new adolescent patients.
Threshold for medication initiation was 350 cells/μl or less.
Results: 52 records were reviewed. Nearly 1/3 (31%) met criteria
for therapy, with 33% of patients 18 to 21 versus 24% of those less
than 18 years of age meeting criteria. 38% of males met criteria
vs. 23% of females. Average viral load of those under 18 was
46,183 vs. 72,902 for those over 18.
Fig. 1. Percentage of patients with CD4 counts below 350.
Conclusions: Almost a third of all adolescents and nearly a quar-
ter of those under 18 met criteria for HAART initiation at ﬁrst
visit. Surprisingly, these young, presumably newly infected indi-
viduals meet criteria for anti-retroviral therapy early in disease.
Efforts to identify HIV-infected adolescents must be intensiﬁed
at all ages
